Drugmakers, Insurers Spend Millions on Drug-Pricing Blame Game
Congressional criticism of pharmaceutical industry middlemen has created a rush of spending on lobbying and advertising as insurers and drugmakers battle over blame for the price of medicine in the US. But not all pharmacy benefits managers say they oppose the legislative efforts. Robyn Crosson, vice president of government relations for Navitus Health Solutions, said the company was “quite supportive” of the bipartisan efforts.
MORE ABOUT Robyn Crosson
Robyn Crosson is the Vice President of Government Relations at Navitus, where she provides strategic direction on government relations thought-leadership initiatives. She oversees building external relationships with state and federal governments, lobbyists and stakeholders. Her team focuses on legislation and proposed rules/regulations concerning the pharmaceutical, PBM and health care industries.
Stay Informed and Connected
Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.
Examining Trends that Drive Informed Decisions
Now Available: 8th Annual Drug Trend Report
See the latest results and access industry insights you need to navigate current trend drivers.